B
RVMD icon

Bailard’s Revolution Medicines RVMD Stock Holding History

Bailard’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-41,500
Closed -$1.14M – 775
2021
Q3 		$1.14M Sell
41,500
-11,000
-21% -$320K 0.04% 250
2021
Q2 		$1.67M Buy
52,500
+20,200
+63% +$705K 0.06% 218
2021
Q1 		$1.48M Buy
32,300
+3,000
+10% +$135K 0.05% 227
2020
Q4 		$1.16M Buy
+29,300
New +$1.16M 0.05% 201

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Bailard's RVMD Position: Q4 2021 in Review

Bailard sold out of Revolution Medicines (RVMD) in Q4 2021, closing a stake of 41,500 shares — an estimated $1.14M sold.

Bailard first reported a position in RVMD in Q4 2020 and held it in 4 quarters. The position peaked at $1.67M in Q2 2021. 117 funds tracked by Wall St. Rank hold RVMD as of Q4 2021.

  • Bailard reported no remaining Revolution Medicines position as of Q4 2021 after selling out during the quarter.
  • Bailard sold 41,500 Revolution Medicines shares in Q4 2021, an estimated $1.14M.
  • Bailard first reported a position in Revolution Medicines in Q4 2020 and held it in 4 quarters.
  • Bailard's Revolution Medicines position peaked at $1.67M in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2021.

Based on Bailard's 13F filing for Q4 2021, filed 10 Feb 2022.